The latest news effecting cancer patients and oncology service delivery during the COVID-19 pandemic
Women receiving standard treatment in New York City for ovarian, uterine, and cervical cancers are not at increased risk of being hospitalised for or dying from COVID-19 due to their cancer, a new study shows. The researchers found that neither having cancer nor receiving treatment for it, which can come with its own toxicities, worsened COVID-19 disease outcomes. Led by researchers at NYU Langone’s Perlmutter Cancer Center and NYU Grossman School of Medicine, the study showed that 121 women, ages 51 to 63, who were receiving standard treatments for such malignancies and who contracted the pandemic coronavirus had similar rates…